Treating Angina: How to Leverage the Placebo Effect!
- Welcome and Angina as a Therapeutic Goal – Redefining Success
- Treating Angina: How to Leverage the Placebo Effect!
- The MDT Discussion – Defining Standards
- LIVE CASES: MVD Case Physiology - Defining Target Lesion, Bystander Disease, and INOCA Patient - How to Perform Full Physiology
- Myocardial Bridge – Physiology and Guide to Assessment and Treatment and Morning Summary
The 5th annual CORE meeting (16 and 17 June 2021) was hosted by Radcliffe Cardiology in collaboration with Optima Education and Abbott Vascular.
The meeting was led by Course Directors Prof Adrian Banning, Prof Evald Christiansen, Dr Jonathan Hill and Prof James Spratt and streamed from our London, Copenhagen, and Dublin hubs.
CORE 2021 focuses on contemporary standards of clinical practice, complex lesion and patient strategies and advanced diagnostic and treatment methods. The goal of CORE is to ensure procedural efficiencies while achieving durable patient outcomes, review patient care beyond intervention and discuss the best practices and innovation outside the catheterisation lab.
More from this programme
CORE 2021 – Day 1: Morning – Physiology
CORE 2021 – Day 1: Afternoon – Bifurcation Management
CORE 2021 – Day 2: Morning – Durable Outcomes
CORE 2021 – Day 2: Afternoon – Beyond Intervention
Interventional Cardiology Consultant
Dr Rasha Al-Lamee is an interventional cardiology consultant at Imperial College Healthcare NHS Trust, London, UK.
Dr Al-Lamee studied at the University of Oxford and University College London. She completed her training in clinical cardiology on the north-west London cardiology rotation in 2013, and completed her PhD at Imperial College London in 2018.
Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is lead author of the primary publication in The Lancet. Dr Al-Lamee has more than 50 peer-reviewed publications and has presented at international cardiology conferences worldwide.
Clinical Associate Professor, Aarhus University Hospital, Denmark
Dr Evald Høj Christiansen is an Associate Professor in the Cardiology Department of Aarhus University Hospital. He is an interventional cardiologist with 15 years' of experience in the field. His main interest is chronic total occlusions, bifurcations, coronary imaging, physiologic evaluations of coronary artery disease, and TAVR. He has performed a series of studies in this area and has conducted many clinical trials.
Dr Thomas Engstrøm MD is currently head of interventional cardiology at Rigshospital in Copenhagen. Engstrøm studied at the University of Copenhagen and trained at Gentofte University Hospital, Skejby University Hospital and Rigshospitalet in Denmark. He is the author of more than 120 scientific articles in peer-reviewed journals.
Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden
Oskar Angeras is a cardiologist in the Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden
Senior Consultant, Department of Cardiology at Danderyds Sjukhus AB
Jonas Persson is a Senior Consultant, Department of Cardiology at Danderyds Sjukhus AB.